Prevalence of hemoglobinopathies in school children: the importance of using confirmatory methods by Tavares, Cristiane Fernandes de Freitas et al.
*Correspondence: A. M. de Souza. Laboratório de Hematologia. Departamento 
de Análises Clínicas, Toxicológicas e Bromatológicas. Faculdade de Ciências 
Farmacêuticas de Ribeirão Preto. Universidade de São Paulo. Av. do Café, s/n 
- Monte Alegre - Bloco M, 20 andar, Sala 053-A. 14040-903 - Ribeirão Preto, 
SP, Brasil. E-mail: amsouza@fcfrp.usp.br
A
rt
ic
leBrazilian Journal of 
Pharmaceutical Sciences
vol. 51, n. 2, apr./jun., 2015
http://dx.doi.org/10.1590/S1984-82502015000200013
Prevalence of hemoglobinopathies in school children: the 
importance of using confirmatory methods
Cristiane Fernandes de Freitas Tavares, Jacqueline da Silva Guimarães, Ana Maria de Souza*
Department of Clinical Analysis, Toxicology and Food Science, Faculty of Pharmaceutical Sciences of Ribeirão Preto, 
University of São Paulo, Ribeirão Preto, SP, São Paulo, Brazil
The hemoglobinopathies are included among the most common genetic diseases in the world. In Brazil, 
hemoglobinopathies are related to the diversity of racial backgrounds and the degree of interbreeding. The 
study focused on the prevalence of hemoglobinopathies using conventional and confirmatory laboratory 
tests in children from public schools in Ribeirão Preto-SP. The study involved the participation of 427 
children between six and nine years of age. Hematologic evaluation, hemoglobin electrophoresis on 
cellulose acetate at alkaline pH, quantification of hemoglobin fractions by high performance liquid 
chromatography (HPLC) and detection of -α3.7 deletion for α thalassemia by polymerase chain reaction 
were performed. The results of hemoglobin electrophoresis on cellulose acetate and HPLC of the 
children studied showed the presence of 30 children (7%) with hemoglobinopathies. Eleven children 
presented results indicating suspicion of S/β-thalassemia; their parents and/or siblings were evaluated 
and confirmed the presence of only Hb S. The analysis of deletion -α3.7 to characterize α-thalassemias 
sampling performed on 207 participants identified 26 children (12.6%) with deletion -α3.7. Thus, 54 
(12.6%) of the children studied present this genetic alteration. For the detection of α-thalassemias it is 
necessary to use confirmatory methods such as molecular analysis and evaluation of family members in 
doubtful cases to facilitate genetic counseling in families, in which deletion -α3.7 is more frequent in Brazil. 
Uniterms: Hemoglobinopathy. Hemoglobin electrophoresis. High performance liquid chromatography/
quantitative analysis. Polymerase chain reaction. 
As hemoglobinopatias estão incluídas nas doenças genéticas mais comuns no mundo. No Brasil, as 
hemoglobinopatias são relatadas pela diversidade racial e o grau de miscigenação. O estudo focou a 
prevalência das hemoglobinopatias usando métodos laboratoriais convencionais como a eletroforese de 
hemoglobina em acetato de celulose em pH alcalino e confirmatório por reação em cadeia de polimerase 
(PCR) em crianças de escolas públicas de Ribeirão Preto-SP. O estudo envolveu a participação de 427 
crianças entre 6-9 anos de idade. Determinaram-se os valores hematológicos, efetuou-se eletroforese 
de hemoglobina em acetato de celulose em pH alcalino, quantificação das frações de hemoglobina 
por HPLC e a detecção da deleção -α3,7 pela PCR. Os resultados da eletroforese de hemoglobina em 
acetato de celulose e do HPLC, nas crianças estudadas, mostraram a presença de 30 crianças (7%) com 
hemoglobinopatias. Onze crianças apresentaram resultado indicando a suspeita de S/β-talassemia; seus 
pais e/ou irmãos confirmaram a presença de apenas a Hb S. A análise da deleção -α3,7, uma das alterações 
que estão presentes na α-talassemia, realizada em 207 participantes, identificou 26 crianças (12,6%) com 
a deleção -α3,7. Dessa forma, 54 (12,6%) das crianças estudadas apresentam hemoglobinopatias. Para 
a deleção da α-talassemias é necessário utilizar métodos confirmatórios como as análises moleculares 
e avaliação de membros da família, em casos duvidosos, facilitando o aconselhamento genético nas 
famílias, sendo a deleção -α3,7 mais frequente no Brasil. 
Unitermos: Hemoglobinopatias. Eletroforese de hemoglobina. Cromatografia líquida de alta eficiência/
análise quantitativa. Reação em cadeia de polimerase.
C. F. F. Tavares, J. S. Guimarães, A. M. Souza362
INTRODUCTION
The hemoglobinopathies are a group of inherited 
diseases that are classified based on the presence 
of structurally abnormal hemoglobin (Hb) such as 
hemoglobins S, C, D and E, and/or one or more globin 
chain disabilities, known as thalassemias (Clark, Thein, 
2004; Henderson et al., 2009). These pathologies are 
included among the most common genetic diseases in 
the world, with an estimated prevalence of 7% of the 
worldwide population (Melo-Reis et al., 2006; Manca, 
Masala, 2008).
In Brazil, hemoglobinopathies are related to 
the diversity of racial backgrounds and the degree of 
interbreeding, and may be regional. The most frequent 
hemoglobin variants are S and C of African origin, 
however, due to interbreeding these hemoglobins came to 
be found in other ethnic groups (Aigner et al., 2006). The 
impact of population migration increases the combinations 
of abnormal hemoglobins and the variety of mutations 
(Henderson et al., 2009).
In most abnormal hemoglobins a point mutation, 
in other words, a single amino acid substitution occurs. 
Over 1100 hemoglobin variants involving the chains α, 
β, δ and γ have been described (Wagner et al., 2005). In 
the heterozygous state, production of Hb A and variant 
hemoglobin occurs without severe clinical manifestations. 
In the homozygous state, Hb A is absent, thus possibly 
resulting severe anemia. The interaction of two hemoglobin 
variants or a combination of a hemoglobin variant and a 
genetic alteration to thalassemia may still occur (Clark, 
Thein, 2004).
Different types of thalassemia are found in 
the population, the most common being the α and 
β-thalassemias (Galanello et al., 1998; Galanello, Origa, 
2010; Cousens et al., 2010). The α-thalassemia is the most 
common inherited disease in the world. Recent studies 
show that α-thalassemia affects 5% of the worldwide 
population and until recently (Vichinsky, 2010), the 
frequency of this pathology was underestimated due the use 
of inadequate diagnostic methods. In Brazil α-thalassemia 
affects mainly Asian and some African groups. Studies 
show a frequency of 10-12% in some regions and up to 
25% in specific groups. For α-thalassemia in the state of 
São Paulo in Caucasian descendants, the estimated ratio 
is 3% (Bonini-Domingos, 2004).
Mutations or deletions may result in a lack of 
production of globin (β0 and α0) or decreased production 
of these (β+ and α+) (Cunninghan, 2010). Over 95% of 
cases of α-thalassemia are due to deletions, being -α5.2 
and -α 20.5 generally causing α0-thalassemia and -α3.7, -α4.2 
causing α+-talassemia (Weatherall, 2001). Molecular 
analyses indicate a high prevalence of deletion -α3.7 in the 
state of São Paulo (Sonati et al., 1991; Borges et al., 2001; 
Oliveira et al., 2006).
Conventional laboratory diagnosis for α-thalassemia 
can be characterized by precipitation of hemoglobin H, 
visualized by supravital staining. This diagnosis can be 
difficult when there is a concomitant hemoglobinopathy 
such as Hb S, Hb C, Hb E and β-thalassemia, because of 
the decrease or absence of Hb H and cellular inclusions 
(Chui et al., 2003).
In general, the most used method for the identification 
of hemoglobinopathies is hemoglobin electrophoresis on 
cellulose acetate at alkaline pH, however its sensitivity is 
limited, especially in the case of isoform co-migration, 
such as Hb S, Lepore and Hb D (Chinelato-Fernandes 
et al., 2003). Thus, confirmatory tests are required, such 
as acid agarose gel electrophoresis, although there is 
controversy regarding the distinction of hemoglobins D 
and G, and O and E (Ondei et al., 2007). High-performance 
liquid chromatography (HPLC) and molecular techniques 
such as polymerase chain reaction (PCR) and sequencing 
the gene are more accurate methods for the diagnosis of 
hemoglobinopathies (Bertholo, Moreira, 2006; Wenning 
et al., 2000; Bonini-Domingos, 2004).
The combined analysis of all methods in the 
diagnosis of hemoglobinopathies is the most appropriate 
since each method alone has limitations and can cause 
a misinterpretation of results (Hughes et al., 2009). 
Thus, this study aimed to evaluate the prevalence of 
hemoglobinopathies using conventional and confirmatory 
laboratory tests such as hemoglobin electrophoresis, 
quantification of hemoglobin fractions by HPLC, and 
analysis of the deletion that causes more frequent 
α-thalassemia (-α3.7) in southeast Brazil (Wenning et al., 
2000; Bonini-Domingos, 2004), also occurring in children 
from public schools in Ribeirão Preto-SP, by molecular 
biology.
MATERIAL AND METHODS
The study group included 427 children between 
six and nine years of age of both genders, recruited from 
state and municipal schools in the city of Ribeirão Preto-
SP, namely: Centro Municipal de Educação Infantil 
Virgílio Salata, Escola Estadual Antônio Diederichsen, 
Escola Estadual Dr. Tomas Alberto Whatelly, EMEFEM 
Dom Luiz Do Amaral Mousinho, and Escola Estadual 
Dom Alberto José Gonçalves. Participation in this study 
was at the consent endorsed by their parents. This study 
was approved by the Ethics Committee of the Faculty of 
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Dentistry of Ribeirão Preto, University of São Paulo (case 
no. 2006.1.797.58.5).
Ten milliliters (mL) of blood were collected 
and  p l aced  in  a  t ube  con ta in ing  d ipo ta s s ium 
ethylenediaminetetraacetic acid (K2 EDTA) 10%, which 
was used in the following determinations: hematologic 
evaluation using automatic counter Micros 45- Horiba 
ABX®; hemoglobin electrophoresis on cellulose acetate 
at alkaline pH, according to Naoum (1999); quantification 
of hemoglobin fractions by HPLC Variant II Bio-Rad® 
automated system (β-thalassemia Short Program kit); and 
extraction of genetic material to perform the PCR.
For detection of deletion -α3.7 the specific primers 
(Dodé et al., 1993): 5’ CCA TGC CTG GCA CGT TTG 
CTG AGG 3’(C9 primer); 5’ GAT GCA CCC ACT GGA 
CTC CT 3’(C10 primer) were used. The PCR reaction was 
processed in a thermocycler (Eppendorf Mastercycle), 30 
cycles being performed at 94 oC/2 min., 56 oC/1 min., 72 
oC/2 min., preceded by an initial heat-denaturation step 
at 94 oC/5 min. and followed by a final extension step at 
72 oC/10 min. The mixture was subjected to horizontal 
electrophoresis on a 1% agarose gel with ethidium 
bromide, with a running time of 1 hour and 20 minutes at 
90 volts, 220 mA. Then the gel was exposed to UV light 
for visualization of the presented bands.
Thirteen parents and two brothers participated 
in the study in order to confirm the results of children 
who showed the presence of Hb S and increased Hb A2, 
suggestive of hemoglobinopathy HbS/β-thalassemia. 
Five mL of blood were collected and placed into a tube 
containing K2 EDTA, which was used for the identification 
and quantification of hemoglobin fractions by HPLC.
RESULTS AND DISCUSSION
The results of hemoglobin electrophoresis 
on cellulose acetate and HPLC of the 427 children 
studied indicated the presence of 30 children (7%) with 
hemoglobinopathies, being 14 with increased Hb A2, 
consistent with the phenotype of β-thalassemia (β+ or 
TABLE I - Distribution of hemoglobinopathies in the studied children utilizing hemoglobin electrophoresis on cellulose acetate 
and HPLC methodology 
Hemoglobinopathies Number of cases and percentage ratios of the total participants
Number of cases and percentage ratios in 
30 children with hemoglobinopathies
β-talassemia 14 / 3,3% 14 / 46,7%
Hb S/ Hb A2 ↑ 11 / 2,6% 11 / 36,7%
Hb AS 04 / 0,94% 04 / 13,3%
Hb AC 01 / 0,24% 01 / 3,3%
FIGURE 1 - Distribution of hemoglobinopathies in the 427 
studied children utilizing hemoglobin electrophoresis on 
cellulose acetate and HPLC methodology. 
β0); 11 with increased Hb A2 and the presence of Hb S, 
consistent with the phenotype of Hb S/β-thalassemia; 4 
with the presence of Hb S carriers of sickle cell trait and 1 
with the presence of Hb C, indicating heterozygosity for 
the Hb C disease (Table I, Figure 1).
The determination of the levels of Hb A2 of 11 
participants with suspected Hb S/β-thalassemia was 
performed by HPLC and the fractions obtained by elution 
in electrophoresis on cellulose acetate. The median Hb 
A2 levels determined by HPLC and elution were 6.3% 
(± 1.1) and 7.0% (± 1.6), respectively, with no significant 
statistical difference (p > 0.05). A survey of quantitative 
and qualitative changes of hemoglobin fractions in 
11 parents and/or siblings by HPLC only detected the 
presence of Hb S, discarding the suspicion S/β-thalassemia 
in children. 
The analysis of deletion -α3.7, featuring α-thalassemia 
was performed in 207 study participants verifying the 
presence of 26 children (12.6%) carrying the deletion, 
being 24 heterozygous and 2 homozygous.
Together the analyses showed a total of 54 children, 
12.6% of the children studied, showing some qualitative 
or quantitative change of the globin chains, namely: 15 
(3.5%) women with Hb S, 1 (0.24 %) Hb C and 14 (3.3%) 
with β-thalassemia minor (Table II, Figure 2).
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Among patients with hemoglobinopathies, 27 
(50%) were anemic according to WHO criteria, i.e., Hb 
less than 11.5 g/dL for children under 12 years of age 
of both genders, 8 (14.8%) of them showed only mild 
hypochromia and the remainder (35.2%) showed no 
significant changes.
In our study the number of carriers of the sickle 
cell trait (3.5%) was apparently higher than reported in a 
review by Murao and Ferraz (2007), in which the authors 
estimate 1.9% of patients with Hb S in the state of Sao 
Paulo. A prevalence of approximately 3% of patients 
with β-thalassemia in the state of São Paulo is estimated 
(Bonini-Domingos, 2004). In our study a prevalence of 
3.3%, very close to the above, was observed. There was 
the presence of 12.6% of α-thalassemia, results close to the 
literature (Head et al., 2004), which indicates prevalence 
of between 10 and 20% in our population. These numbers 
are quite significant and justify the need for more extensive 
research in the city of Ribeirão Preto to characterize the 
prevalence in the population. 
On these results the necessity of conducting prenatal 
testing and research of family cases of hemoglobinopathies 
in our population is evident.
Neonatal screening programs follow the standards 
of the National Program for Newborn Screening (Ministry 
of Health decree No. 822/01) that recommends the 
use of two presumptive methods for determining the 
electrophoretic profile. Currently, screening programs 
replaced the traditional methods by using isoelectric 
focusing electrophoresis and HPLC. Despite new 
presumptive methods having better sensitivity and 
specificity, they are susceptible to interference and in some 
cases such as in the diagnosis of α-talassemia the use of 
molecular methodology is required (Hughes et al., 2009). 
Our study proved this since the number of patients with 
hemoglobinopathies rose 5.6% after performing PCR for 
detection of α-thalassemia.
The use of HPLC has shown to be more sensitive 
and specific, and with a better reproducibility for the 
determination of the Hb A2 method. However it is argued 
that the percentage of Hb A2 measured by HPLC can 
be affected by the presence of hemoglobin S (HbS) in 
heterozygous individuals for β-thalassemia. This is due 
to reduced affinity of the βS to α chains, which leads to 
the free α to match δ chains, increasing Hb A2, and co-
elution of Hb with Hb A2, falsely elevating its percentage 
(Head et al., 2004; Kalleas et al., 2007). No significant 
differences were observed in quantifying the levels of 
Hb A2, performed by the methods of electrophoresis 
on cellulose acetate for elution and HPLC. To confirm 
suggestive cases of Hb S/β-thalassemia, parents and/or 
siblings of these children were evaluated, verifying in all 
cases only the presence of HbS and normal levels of Hb 
A2, thus inferring that the children had only the sickle cell 
trait. Probably the increase in Hb A2 was found in these 
children due to the combination of free α and δ chains and 
not presenting mutations that compromise the synthesis 
of β chains.
CONCLUSION
We  c o n c l u d e  t h a t  i n  o r d e r  t o  d e t e c t 
hemoglobinopathies, the use of confirmatory methods 
such as molecular analysis for the search of α-thalassemia 
and the investigation of relatives of the doubtful cases are 
required. Although it has been investigated only for the 
most frequent deletion for α-thalassemia, α3.7 it is now 
possible to state the importance of confirmatory methods. 
Only then we can ensure accurate diagnosis and facilitate 
genetic counseling in families where there are carriers of 
these pathologies.
TABLE II - Distribution of hemoglobinopathies in the studied 
children utilizing hemoglobin electrophoresis on cellulose 
acetate, HPLC and PCR methodology
Hemoglobinopathies
Number of cases and 
percentage ratios of the total 
participants
α-talassemia 24 / 11,6%
Hb AS 15 / 3,5%
β-talassemia 12 / 2,8%
α/β-talassemia 02 / 0,96%
Hb AC 01 / 0,24%
FIGURE 2 – Frequencies of hemoglobinopathies in the 427 
studied children utilizing hemoglobin electrophoresis on 
cellulose acetate and HPLC, and the 207 studied children 
utilizing PCR.
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